Alexander A. Fingerle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexander A. Fingerle has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- Franz Pfeiffer
Department of Diagnostic and Interventional Radiology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany
8 shared publications - Andreas Philipp Sauter
Department of Diagnostic and Interventional Radiology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany
7 shared publications - Daniela Pfeiffer
Department of Diagnostic and Interventional Radiology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany
7 shared publications - Peter Benjamin Noël
Department of Radiology Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA
7 shared publications - Ernst J. Rummeny
Department of Diagnostic and Interventional Radiology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany
6 shared publications - Florian Tilman Gassert
Department of Diagnostic and Interventional Radiology, TUM School of Medicine and Health, TUM University Hospital, Technical University of Munich, Munich, Germany
6 shared publications
Latest Publications
- Open Access
- 27 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0316104
Simulated low-dose dark-field radiography for detection of COVID-19 pneumonia
Background: Dark-field radiography has been proven to be a promising tool for the assessment of various lung diseases. Purpose: To evaluate the potential of dose reduction in dark-field chest radiography for the detection of the Coronavirus SARS-CoV-2 (COVID-19) pneumonia. Materials and methods: Patients aged at least 18 years with a medically indicated chest computed tomography scan (CT scan) were screened for participation in a prospective study between October 2018 and December 2020. Patients were included if they had a CO-RADS (COVID-19 Reporting and Data System) score ≥ 4 (COVID-19 group) or if they had no pathologic lung changes (controls). A total of 89 participants with a median age of 60 years (interquartile range 48 to 68 yrs.) were included in this study. Dark-field and attenuation-based radiographs were simultaneously obtained by using a prototype system for dark-field radiography. By modifying the image reconstruction algorithm, low-dose radiographs were simulated based on real participant images. The simulated radiographs corresponded to 50%, 25%, and 13% of the full dose (41.9 μSv, median value). Four experienced radiologists served as blinded readers assessing both image modalities, displayed side by side in random order. The presence of COVID-19-associated lung changes was rated on a scale from 1 to 6. The readers’ diagnostic performance was evaluated by analyzing the area under the receiver operating characteristic curves (AUC) using Obuchowski’s method. Also, the dark-field images were analyzed quantitatively by comparing the dark-field coefficients within and between the COVID-19 and the control group. Results: The readers’ diagnostic performance in the image evaluation, as described by the AUC value (where a value of 1 corresponds to perfect diagnostic accuracy), did not differ significantly between the full dose images (AUC = 0.86) and the simulated images at 50% (AUC = 0.86) and 25% of the full dose(AUC = 0.84) (p>0.050), but was slightly lower at 13% dose (AUC = 0.82) (p = 0.038). For all four radiation dose levels, the median dark-field coefficients within groups were identical but different significantly by 15% between the controls and the COVID-19 pneumonia group (p<0.001). Conclusion: Dark-field imaging can be used to diagnose the Coronavirus SARS-CoV-2 (COVID-19) pneumonia with a median dose of 10.5 μSv, which corresponds to 25% of the original dose used for dark-field chest imaging.
- 27 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0316104
Open AccessSimulated low-dose dark-field radiography for detection of COVID-19 pneumonia
Background: Dark-field radiography has been proven to be a promising tool for the assessment of various lung diseases. Purpose: To evaluate the potential of dose reduction in dark-field chest radiography for the detection of the Coronavirus SARS-CoV-2 (COVID-19) pneumonia. Materials and methods: Patients aged at least 18 years with a medically indicated chest computed tomography scan (CT scan) were screened for participation in a prospective study between October 2018 and December 2020. Patients were included if they had a CO-RADS (COVID-19 Reporting and Data System) score ≥ 4 (COVID-19 group) or if they had no pathologic lung changes (controls). A total of 89 participants with a median age of 60 years (interquartile range 48 to 68 yrs.) were included in this study. Dark-field and attenuation-based radiographs were simultaneously obtained by using a prototype system for dark-field radiography. By modifying the image reconstruction algorithm, low-dose radiographs were simulated based on real participant images. The simulated radiographs corresponded to 50%, 25%, and 13% of the full dose (41.9 μSv, median value). Four experienced radiologists served as blinded readers assessing both image modalities, displayed side by side in random order. The presence of COVID-19-associated lung changes was rated on a scale from 1 to 6. The readers’ diagnostic performance was evaluated by analyzing the area under the receiver operating characteristic curves (AUC) using Obuchowski’s method. Also, the dark-field images were analyzed quantitatively by comparing the dark-field coefficients within and between the COVID-19 and the control group. Results: The readers’ diagnostic performance in the image evaluation, as described by the AUC value (where a value of 1 corresponds to perfect diagnostic accuracy), did not differ significantly between the full dose images (AUC = 0.86) and the simulated images at 50% (AUC = 0.86) and 25% of the full dose(AUC = 0.84) (p>0.050), but was slightly lower at 13% dose (AUC = 0.82) (p = 0.038). For all four radiation dose levels, the median dark-field coefficients within groups were identical but different significantly by 15% between the controls and the COVID-19 pneumonia group (p<0.001). Conclusion: Dark-field imaging can be used to diagnose the Coronavirus SARS-CoV-2 (COVID-19) pneumonia with a median dose of 10.5 μSv, which corresponds to 25% of the original dose used for dark-field chest imaging.
- Open Access
- 21 June 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Medical Imaging
- Vol. 43 (1) , 28-38
Correction for Mechanical Inaccuracies in a Scanning Talbot-Lau Interferometer
Grating-based X-ray phase-contrast and in particular dark-field radiography are promising new imaging modalities for medical applications. Currently, the potential advantage of dark-field imaging in early-stage diagnosis of pulmonary diseases in humans is being investigated. These studies make use of a comparatively large scanning interferometer at short acquisition times, which comes at the expense of a significantly reduced mechanical stability as compared to tabletop laboratory setups. Vibrations create random fluctuations of the grating alignment, causing artifacts in the resulting images. Here, we describe a novel maximum likelihood method for estimating this motion, thereby preventing these artifacts. It is tailored to scanning setups and does not require any sample-free areas. Unlike any previously described method, it accounts for motion in between as well as during exposures.
- 21 June 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Medical Imaging
- Vol. 43 (1) , 28-38
Open AccessCorrection for Mechanical Inaccuracies in a Scanning Talbot-Lau Interferometer
Grating-based X-ray phase-contrast and in particular dark-field radiography are promising new imaging modalities for medical applications. Currently, the potential advantage of dark-field imaging in early-stage diagnosis of pulmonary diseases in humans is being investigated. These studies make use of a comparatively large scanning interferometer at short acquisition times, which comes at the expense of a significantly reduced mechanical stability as compared to tabletop laboratory setups. Vibrations create random fluctuations of the grating alignment, causing artifacts in the resulting images. Here, we describe a novel maximum likelihood method for estimating this motion, thereby preventing these artifacts. It is tailored to scanning setups and does not require any sample-free areas. Unlike any previously described method, it accounts for motion in between as well as during exposures.
- Open Access
- 26 May 2023
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 58 (11) , 775-781
Dark-Field Chest Radiography Outperforms Conventional Chest Radiography for the Diagnosis and Staging of Pulmonary Emphysema
Objectives: Dark-field chest radiography (dfCXR) has recently reached clinical trials. Here we compare dfCXR to conventional radiography for the detection and staging of pulmonary emphysema. Materials and Methods: Subjects were included after a medically indicated computed tomography (CT) scan, showing either no lung impairments or different stages of emphysema. To establish a ground truth, all CT scans were assessed by 3 radiologists assigning emphysema severity scores based on the Fleischner Society classification scheme. Participants were imaged at a commercial chest radiography device and at a prototype for dfCXR, yielding both attenuation-based and dark-field images. Three radiologists blinded to CT score independently assessed images from both devices for presence and severity of emphysema (no, mild, moderate, severe). Statistical analysis included evaluation of receiver operating characteristic curves and pairwise comparison of adjacent Fleischner groups using an area under the curve (AUC)–based z test with a significance level of 0.05. Results: A total of 88 participants (54 men) with a mean age of 64 ± 12 years were included. Compared with conventional images (AUC = 0.73), readers were better able to identify emphysema with images from the dark-field prototype (AUC = 0.85, P = 0.005). Although ratings of adjacent emphysema severity groups with conventional radiographs differed only for trace and mild emphysema, ratings based on images from the dark-field prototype were different for trace and mild, mild and moderate, and moderate and confluent emphysema. Conclusions: Dark-field chest radiography is superior to conventional chest radiography for emphysema diagnosis and staging, indicating the technique's potential as a low-dose diagnostic tool for emphysema assessment.
- 26 May 2023
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 58 (11) , 775-781
Open AccessDark-Field Chest Radiography Outperforms Conventional Chest Radiography for the Diagnosis and Staging of Pulmonary Emphysema
Objectives: Dark-field chest radiography (dfCXR) has recently reached clinical trials. Here we compare dfCXR to conventional radiography for the detection and staging of pulmonary emphysema. Materials and Methods: Subjects were included after a medically indicated computed tomography (CT) scan, showing either no lung impairments or different stages of emphysema. To establish a ground truth, all CT scans were assessed by 3 radiologists assigning emphysema severity scores based on the Fleischner Society classification scheme. Participants were imaged at a commercial chest radiography device and at a prototype for dfCXR, yielding both attenuation-based and dark-field images. Three radiologists blinded to CT score independently assessed images from both devices for presence and severity of emphysema (no, mild, moderate, severe). Statistical analysis included evaluation of receiver operating characteristic curves and pairwise comparison of adjacent Fleischner groups using an area under the curve (AUC)–based z test with a significance level of 0.05. Results: A total of 88 participants (54 men) with a mean age of 64 ± 12 years were included. Compared with conventional images (AUC = 0.73), readers were better able to identify emphysema with images from the dark-field prototype (AUC = 0.85, P = 0.005). Although ratings of adjacent emphysema severity groups with conventional radiographs differed only for trace and mild emphysema, ratings based on images from the dark-field prototype were different for trace and mild, mild and moderate, and moderate and confluent emphysema. Conclusions: Dark-field chest radiography is superior to conventional chest radiography for emphysema diagnosis and staging, indicating the technique's potential as a low-dose diagnostic tool for emphysema assessment.
- 1 December 2022
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 4 (6) , e220093
Assessment of Inflation in a Human Cadaveric Lung with Dark-Field Chest Radiography
Dark-field chest radiography signal intensity appeared to correlate with inflation status in a cadaveric lung.
- 1 December 2022
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 4 (6) , e220093
Assessment of Inflation in a Human Cadaveric Lung with Dark-Field Chest Radiography
Dark-field chest radiography signal intensity appeared to correlate with inflation status in a cadaveric lung.
- 1 June 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 696-698
X-ray Dark-Field CT for Early Detection of Radiation-induced Lung Injury in a Murine Model
Online supplemental material is available for this article.
- 1 June 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 696-698
X-ray Dark-Field CT for Early Detection of Radiation-induced Lung Injury in a Murine Model
Online supplemental material is available for this article.
- 1 April 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (1) , 119-127
Qualitative and Quantitative Assessment of Emphysema Using Dark-Field Chest Radiography
Dark-field chest radiography shows dark-field signal intensity losses that correspond to emphysematous areas found on chest CT images in participants with emphysema. Background Dark-field chest radiography allows for assessment of lung alveolar structure by exploiting wave optical properties of x-rays. Purpose To evaluate the qualitative and quantitative featur...
- 1 April 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (1) , 119-127
Qualitative and Quantitative Assessment of Emphysema Using Dark-Field Chest Radiography
Dark-field chest radiography shows dark-field signal intensity losses that correspond to emphysematous areas found on chest CT images in participants with emphysema. Background Dark-field chest radiography allows for assessment of lung alveolar structure by exploiting wave optical properties of x-rays. Purpose To evaluate the qualitative and quantitative featur...
- 1 November 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 301 (2) , 389-395
X-ray Dark-Field Chest Imaging: Qualitative and Quantitative Results in Healthy Humans
This study introduces the qualitative and quantitative characteristics of x-ray dark-field chest radiographs in healthy humans. Background X-ray dark-field radiography takes advantage of the wave properties of x-rays, with a relatively high signal in the lungs due to the many air-tissue interfaces in the alveoli. Purpose To...
- 1 November 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 301 (2) , 389-395
X-ray Dark-Field Chest Imaging: Qualitative and Quantitative Results in Healthy Humans
This study introduces the qualitative and quantitative characteristics of x-ray dark-field chest radiographs in healthy humans. Background X-ray dark-field radiography takes advantage of the wave properties of x-rays, with a relatively high signal in the lungs due to the many air-tissue interfaces in the alveoli. Purpose To...
- Open Access
- 30 December 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (12) , e0244707
Coronary calcium scoring assessed on native screening chest CT imaging as predictor for outcome in COVID-19: An analysis of a hospitalized German cohort
Background: Since the outbreak of the COVID-19 pandemic, a number of risk factors for a poor outcome have been identified. Thereby, cardiovascular comorbidity has a major impact on mortality. We investigated whether coronary calcification as a marker for coronary artery disease (CAD) is appropriate for risk prediction in COVID-19. Methods: Hospitalized patients with COVID-19 (n = 109) were analyzed regarding clinical outcome after native computed tomography (CT) imaging for COVID-19 screening. CAC (coronary calcium score) and clinical outcome (need for intensive care treatment or death) data were calculated following a standardized protocol. We defined three endpoints: critical COVID-19 and transfer to ICU, fatal COVID-19 and death, composite endpoint critical and fatal COVID-19, a composite of ICU treatment and death. We evaluated the association of clinical outcome with the CAC. Patients were dichotomized by the median of CAC. Hazard ratios and odds ratios were calculated for the events death or ICU or a composite of death and ICU. Results: We observed significantly more events for patients with CAC above the group’s median of 31 for critical outcome (HR: 1.97[1.09,3.57], p = 0.026), for fatal outcome (HR: 4.95[1.07,22.9], p = 0.041) and the composite endpoint (HR: 2.31[1.28,4.17], p = 0.0056. Also, odds ratio was significantly increased for critical outcome (OR: 3.01 [1.37, 6.61], p = 0.01) and for fatal outcome (OR: 5.3 [1.09, 25.8], p = 0.02). Conclusion: The results indicate a significant association between CAC and clinical outcome in COVID-19. Our data therefore suggest that CAC might be useful in risk prediction in patients with COVID-19.
- 30 December 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (12) , e0244707
Open AccessCoronary calcium scoring assessed on native screening chest CT imaging as predictor for outcome in COVID-19: An analysis of a hospitalized German cohort
Background: Since the outbreak of the COVID-19 pandemic, a number of risk factors for a poor outcome have been identified. Thereby, cardiovascular comorbidity has a major impact on mortality. We investigated whether coronary calcification as a marker for coronary artery disease (CAD) is appropriate for risk prediction in COVID-19. Methods: Hospitalized patients with COVID-19 (n = 109) were analyzed regarding clinical outcome after native computed tomography (CT) imaging for COVID-19 screening. CAC (coronary calcium score) and clinical outcome (need for intensive care treatment or death) data were calculated following a standardized protocol. We defined three endpoints: critical COVID-19 and transfer to ICU, fatal COVID-19 and death, composite endpoint critical and fatal COVID-19, a composite of ICU treatment and death. We evaluated the association of clinical outcome with the CAC. Patients were dichotomized by the median of CAC. Hazard ratios and odds ratios were calculated for the events death or ICU or a composite of death and ICU. Results: We observed significantly more events for patients with CAC above the group’s median of 31 for critical outcome (HR: 1.97[1.09,3.57], p = 0.026), for fatal outcome (HR: 4.95[1.07,22.9], p = 0.041) and the composite endpoint (HR: 2.31[1.28,4.17], p = 0.0056. Also, odds ratio was significantly increased for critical outcome (OR: 3.01 [1.37, 6.61], p = 0.01) and for fatal outcome (OR: 5.3 [1.09, 25.8], p = 0.02). Conclusion: The results indicate a significant association between CAC and clinical outcome in COVID-19. Our data therefore suggest that CAC might be useful in risk prediction in patients with COVID-19.
- 2 January 2020
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 192 (S 01) , S7
Sparse-Sampling Computertomografie (SpSCT) zur Dosisreduktion bei der Diagnostik von Lungenarterienembolien: erste Ergebnisse einer neuen CT-Technologie
Zielsetzung Im Rahmen dieser Studie sollten simulierte Sparse-Sampling Computertomografie (SpSCT) Bilder verschiedener Dosisstufen hinsichtlich subjektiver und objektiver Kriterien bezüglich der Diagnostik von Lungenarterienembolien (LAE) evaluiert werden. Material und Methoden 20 klinische CT-Pulmonalangiografien (50% mit der Diagnose LAE) wurden verwendet, um Datensätze mit verschiedenen Dosisleveln (DL) zu simulieren; hierbei wurden 6 Stufen mit 100%-50%-25%-12,5%-6,3%-3,1% der ursprünglichen Dosis generiert. Bei diesen voll-Sampling (full sampling, FS) Daten wurde jede Projektion für die Bilderstellung verwendet. Von diesen FS-Daten wurde nun jede zweite (2-SpSCT) oder vierte (4-SpSCT) Projektion verwendet, um Sparse-Sampling Datensätze zu simulieren. Jeder dieser Datensätze wurde von vier verblindeten Radiologen hinsichtlich subjektiver Kriterien evaluiert und die Richtigkeit der Diagnose wurde ausgewertet. Als objektiver Parameter wurde zusätzlich das Kontrast-zu-Rausch Verhältnis (KRV) bestimmt. Ergebnisse Die Sensitivität betrug 100% mit 2-SpSCT und 4-SpSCT beim 25% und 12,5% DL, unabhängig von der Lokalisation der LAE (eine Subgruppe 98,5%). Mit 2-SpSCT und 4-SpSCT konnten bei allen Dosisstufen höhere Sensitivitäten und Spezifitäten erreicht werden als mit FS. Die subjektive Bildqualität war bei allen DL mit 4-SpSCT signifikant höher als mit FS (p<0.01). Lediglich mit 4-SpSCT wurden allen Datensätzen beim 12,5% DL eine diagnostische Bildqualität bestätigt. SpSCT führte bei niedrigen Dosisstufen zu einem signifikant höheren KRV als FS. Schlußfolgerungen Mit SpSCT wäre in der aktuellen Studie eine Dosisreduktion von 88% bei gleichzeitig beibehaltener hoher Bildqualität und voller diagnostischer Konfidenz möglich, entsprechend einer effektiven Dosis von 0.38 mSv. Zukünftig könnte somit durch SpSCT die Dosis für den Patienten reduziert werden oder die Dosis pro Projektion bei insgesamt konstanter Dosis erhöht werden, wodurch insbesondere bei Niedrigdosisuntersuchungen eine Bildverbesserung erreicht werden könnte.
- 2 January 2020
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 192 (S 01) , S7
Sparse-Sampling Computertomografie (SpSCT) zur Dosisreduktion bei der Diagnostik von Lungenarterienembolien: erste Ergebnisse einer neuen CT-Technologie
Zielsetzung Im Rahmen dieser Studie sollten simulierte Sparse-Sampling Computertomografie (SpSCT) Bilder verschiedener Dosisstufen hinsichtlich subjektiver und objektiver Kriterien bezüglich der Diagnostik von Lungenarterienembolien (LAE) evaluiert werden. Material und Methoden 20 klinische CT-Pulmonalangiografien (50% mit der Diagnose LAE) wurden verwendet, um Datensätze mit verschiedenen Dosisleveln (DL) zu simulieren; hierbei wurden 6 Stufen mit 100%-50%-25%-12,5%-6,3%-3,1% der ursprünglichen Dosis generiert. Bei diesen voll-Sampling (full sampling, FS) Daten wurde jede Projektion für die Bilderstellung verwendet. Von diesen FS-Daten wurde nun jede zweite (2-SpSCT) oder vierte (4-SpSCT) Projektion verwendet, um Sparse-Sampling Datensätze zu simulieren. Jeder dieser Datensätze wurde von vier verblindeten Radiologen hinsichtlich subjektiver Kriterien evaluiert und die Richtigkeit der Diagnose wurde ausgewertet. Als objektiver Parameter wurde zusätzlich das Kontrast-zu-Rausch Verhältnis (KRV) bestimmt. Ergebnisse Die Sensitivität betrug 100% mit 2-SpSCT und 4-SpSCT beim 25% und 12,5% DL, unabhängig von der Lokalisation der LAE (eine Subgruppe 98,5%). Mit 2-SpSCT und 4-SpSCT konnten bei allen Dosisstufen höhere Sensitivitäten und Spezifitäten erreicht werden als mit FS. Die subjektive Bildqualität war bei allen DL mit 4-SpSCT signifikant höher als mit FS (p<0.01). Lediglich mit 4-SpSCT wurden allen Datensätzen beim 12,5% DL eine diagnostische Bildqualität bestätigt. SpSCT führte bei niedrigen Dosisstufen zu einem signifikant höheren KRV als FS. Schlußfolgerungen Mit SpSCT wäre in der aktuellen Studie eine Dosisreduktion von 88% bei gleichzeitig beibehaltener hoher Bildqualität und voller diagnostischer Konfidenz möglich, entsprechend einer effektiven Dosis von 0.38 mSv. Zukünftig könnte somit durch SpSCT die Dosis für den Patienten reduziert werden oder die Dosis pro Projektion bei insgesamt konstanter Dosis erhöht werden, wodurch insbesondere bei Niedrigdosisuntersuchungen eine Bildverbesserung erreicht werden könnte.
- Open Access
- 1 January 2020
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 6 (1) , 015038
Liver lesion localisation and classification with convolutional neural networks: a comparison between conventional and spectral computed tomography
Purpose: To evaluate the benefit of the additional available information present in spectral CT datasets, as compared to conventional CT datasets, when utilizing convolutional neural networks for fully automatic localisation and classification of liver lesions in CT images. Materials and Methods: Conventional and spectral CT images (iodine maps, virtual monochromatic images (VMI)) were obtained from a spectral dual-layer CT system. Patient diagnosis were known from the clinical reports and classified into healthy, cyst and hypodense metastasis. In order to compare the value of spectral versus conventional datasets when being passed as input to machine learning algorithms, we implemented a weakly-supervised convolutional neural network (CNN) that learns liver lesion localisation without pixel-level ground truth annotations. Regions-of-interest are selected automatically based on the localisation results and are used to train a second CNN for liver lesion classification (healthy, cyst, hypodense metastasis). The accuracy of lesion localisation was evaluated using the Euclidian distances between the ground truth centres of mass and the predicted centres of mass. Lesion classification was evaluated by precision, recall, accuracy and F1-Score. Results: Lesion localisation showed the best results for spectral information with distances of 8.22 ± 10.72 mm, 8.78 ± 15.21 mm and 8.29 ± 12.97 mm for iodine maps, 40 keV and 70 keV VMIs, respectively. With conventional data distances of 10.58 ± 17.65 mm were measured. For lesion classification, the 40 keV VMIs achieved the highest overall accuracy of 0.899 compared to 0.854 for conventional data. Conclusion: An enhanced localisation and classification is reported for spectral CT data, which demonstrates that combining machine-learning technology with spectral CT information may in the future improve the clinical workflow as well as the diagnostic accuracy.
- 1 January 2020
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 6 (1) , 015038
Open AccessLiver lesion localisation and classification with convolutional neural networks: a comparison between conventional and spectral computed tomography
Purpose: To evaluate the benefit of the additional available information present in spectral CT datasets, as compared to conventional CT datasets, when utilizing convolutional neural networks for fully automatic localisation and classification of liver lesions in CT images. Materials and Methods: Conventional and spectral CT images (iodine maps, virtual monochromatic images (VMI)) were obtained from a spectral dual-layer CT system. Patient diagnosis were known from the clinical reports and classified into healthy, cyst and hypodense metastasis. In order to compare the value of spectral versus conventional datasets when being passed as input to machine learning algorithms, we implemented a weakly-supervised convolutional neural network (CNN) that learns liver lesion localisation without pixel-level ground truth annotations. Regions-of-interest are selected automatically based on the localisation results and are used to train a second CNN for liver lesion classification (healthy, cyst, hypodense metastasis). The accuracy of lesion localisation was evaluated using the Euclidian distances between the ground truth centres of mass and the predicted centres of mass. Lesion classification was evaluated by precision, recall, accuracy and F1-Score. Results: Lesion localisation showed the best results for spectral information with distances of 8.22 ± 10.72 mm, 8.78 ± 15.21 mm and 8.29 ± 12.97 mm for iodine maps, 40 keV and 70 keV VMIs, respectively. With conventional data distances of 10.58 ± 17.65 mm were measured. For lesion classification, the 40 keV VMIs achieved the highest overall accuracy of 0.899 compared to 0.854 for conventional data. Conclusion: An enhanced localisation and classification is reported for spectral CT data, which demonstrates that combining machine-learning technology with spectral CT information may in the future improve the clinical workflow as well as the diagnostic accuracy.